Incyte Names New Board Of Director
Dr Dixon’s prior experience include 30 years in the biopharmaceutical industry involving multiple product launches and new drug approvals across a broad range of therapeutic areas and the
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Headquartered in Phillipsburg, New Jersey, Covidien’s specialty chemicals business, manufactures and markets high-purity chemicals and related products and services under two brand names, JT Baker and Mallinckrodt Laboratory